FDA Puts 16 Drugs on Watch List
Potential Signals of Serious Risks/New Safety Information Identified by AERS, October to December 2011 – http://www.medscape.com/viewarticle/762205?src=mp&spon=38 . Product Name: Active Ingredient (Trade) or Product Class Potential Signal of a Serious Risk/New Safety Information Additional Information (as of February 15, 2012)* Bortezomib (Velcade, Takeda) Death from intrathecal administration (medication error) The Dosage […]
FDA Puts 16 Drugs on Watch List Read More »